Annovis Bio Inc (07X) Stock Price & News

All values in USD	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	-	-	-	-
Cost of goods sold	-	-	-	-
Cost of revenue	-	-	-	-
Research and development expenses	6.29M	8.75M	16.72M	12.01M
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	1.14M	955.15K	1.19M	2.37M
Operating expense	7.43M	9.71M	17.91M	14.38M
Total operating expenses	7.43M	9.71M	17.91M	14.38M
Operating income	-7.43M	-9.71M	-17.91M	-14.38M
Other non operating income	20.00K	-296.00K	268.00K	-603.34K
EBT including unusual items	-7.26M	-9.83M	-17.61M	-14.82M
EBT excluding unusual items	-7.26M	-9.83M	-17.51M	-14.82M
Income tax expense	-	-	-	-
Effective tax rate	-	-	-	-
Other operating expenses	-	-	-	-
Net income	-7.26M	-9.83M	-17.61M	-14.82M
Net profit margin	-	-	-	-
Earnings per share	-0.37	-0.39	-0.63	-0.40
Interest and investment income	152.32K	167.74K	137.80K	160.23K
Interest expense	-	-	-	-
Net interest expenses	152.32K	167.74K	137.80K	160.23K
Depreciation and amortization charges	-	-	-	-
EBITDA	-	-	-	-
Gain or loss from assets sale	-	-	-	-

Finance